SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath shares experienced high volatility following a revenue beat and raised full-year guidance, with traders debating whether the results show enough momentum to support the recent sharp rally or if valuation and narrowing margins remain headwinds. Sentiment is sharply divided between bulls expecting a short squeeze due to high short interest and skeptics who view the performance as insufficient to justify its current price levels.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon shares are trending sharply lower following disappointing second-quarter results, a downward revision to full-year guidance, and concerns regarding slowing traffic and inconsistent product performance. While some traders are attempting to buy the dip, pointing to the company's clean balance sheet and the upcoming arrival of a new CEO, many others are expressing skepticism about a near-term turnaround, citing increased competition and a decline in brand heat.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing retail skepticism and downward price pressure following its Cybercab launch event, which drew criticism for its lack of a public livestream and limited disclosure regarding deployment details. The conversation is dominated by debates over the event's execution, regulatory concerns from the NHTSA, and skepticism regarding the scalability and profitability of the robotaxi business.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending as investors react to a newly expanded AI infrastructure deal with Hewlett Packard Enterprise, while the community remains divided over the stock's valuation and volatility ahead of upcoming earnings. While many retail traders are bullish on the company's AI backlog and potential for a short squeeze, some investors express caution regarding the company's debt levels and macro-related headwinds.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is trending following a record fiscal second-quarter earnings beat, where double-digit revenue growth and surprise profitability in defense and intelligence sectors drove positive sentiment. While traders have expressed frustration over recent volatility and concerns regarding Q3 guidance, many are focused on the company's strong contract pipeline and its long-term potential as a defense and AI infrastructure play.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is receiving attention as investors react to the appointment of Anil Chakravarthy as the new CEO, effective December 1, following the announcement of Shantanu Narayen's transition to executive chair. Market participants are divided on the transition, with some expressing optimism about internal continuity while others voice concern over the timing and the potential impact of competitive pressures in the AI landscape.

Astera Labs, Inc. provides rack-scale AI infrastructure through purpose-built connectivity solutions. The company offers a range of semiconductor-based connectivity solutions designed to address bandwidth, latency, and reliability challenges in AI and cloud data centers. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs is trending as traders speculate on the company's potential inclusion in the S&P 500 during the upcoming rebalancing, which is driving significant interest despite recent volatility. The community remains divided between those viewing the current price as a buying opportunity and those concerned by broader downward trends in the AI connectivity sector.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler is experiencing high volatility as investors weigh strong fiscal fourth-quarter results and positive analyst outlooks against concerns regarding decelerating revenue growth and conservative guidance. The community remains divided, with many traders viewing the stock as undervalued despite recent price target hikes, while others express frustration over the stock's sluggish performance relative to its cybersecurity peers.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending following reports that some Chinese suppliers are halting rare earth shipments to U.S. customers due to geopolitical tensions. While investors are debating the long-term potential of the company's domestic supply chain and its acquisition of Serra Verde Group, sentiment remains highly volatile as market participants react to recent earnings and institutional positioning.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology Group is trending as investors debate the cause of a sharp sell-off, with many traders viewing the stock as significantly oversold following recent earnings results and speculating that the decline is driven by algorithmic selling or market maker manipulation rather than poor fundamentals. While some express frustration with the volatility, others are aggressively buying the dip, citing strong long-term growth prospects in the AI connectivity sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Watch These 2 Energy Stocks — S&P 500 Addition Could Come Before Quarter's End

Equity

Bloom Energy and Cheniere Energy are two of the most likely inclusions in the benchmark index, according to Stephens analyst Melissa Roberts. 

MRK, RPRX Stocks Hit 52-Week Highs – What Drove Today’s Gains?

Merck shares rose on growing confidence in its cancer pipeline, while Royalty Pharma hit a record high as Ziihera’s FDA approval strengthened its royalty opportunity.

If You Invested $1000 In Royalty Pharma Stock 10 Years Ago, You Would Have This Much Today

Royalty Pharma (NASDAQ:RPRX) has outperformed the market over the past 10 years by 27.34% on an annualized basis producing an average annual return of 40.75%. Currently, Royalty Pharma has a market capitalization ofread more...

Here's How Much You Would Have Made Owning Royalty Pharma Stock In The Last 10 Years

Royalty Pharma (NASDAQ:RPRX) has outperformed the market over the past 10 years by 26.07% on an annualized basis producing an average annual return of 39.56%. Currently, Royalty Pharma has a market capitalization ofread more...

Royalty Pharma Locks in $100M Zealand Pharma Funding Pact for Blood Disorder Drug

Royalty Pharma will pay Zealand Pharma $100 million for economic rights tied to rusfertide, with FDA action expected in Q3 of 2026.read more...

Royalty Pharma (RPRX) Crossed Above the 20-Day Moving Average: What That Means for Investors

Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?

Royalty Pharma (RPRX) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Royalty Pharma (RPRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Royalty Pharma (RPRX) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates

Royalty Pharma (RPRX) delivered earnings and revenue surprises of +3.94% and +1.52%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Royalty Pharma Q2 Net Income Declines; Raises 2026 Guidance For Portfolio Receipts

(RTTNews) - Royalty Pharma plc (RPRX) reported that its second quarter net income attributable to Royalty Pharma declined to $18 million from $32 million, last year. Adjusted EBITDA increased to $736 million from $633 million. Total income and other revenues was $674 million comp...

• Reported GAAP EPS of $0.03 down -57.14% YoY
• Reported revenue of $674M up 16.47% YoY
• Royalty Pharma raised its full year 2026 guidance for Portfolio Receipts to between $3,400 million and $3,500 million, representing expected Royalty Receipts growth of 7% to 10% for Royalty Pharma.

Royalty Pharma faced headwinds from a 91% decline in milestone receipts and specific product revenue deterioration, including a 75% drop in Promacta receipts due to generic competition for Royalty Pharma.

Royalty Pharma delivered 14% growth in Royalty Receipts driven by key therapies and expanded its development-stage pipeline to 19 candidates, while executing $1.1 billion in capital deployment for Royalty Pharma.

Royalty Pharma Plc engages in the provision of drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.

Royalty Pharma plc - Ordinary Shares - Class A

Bearish Sentiment

The Federal Reserve hasn't raised rates at all in 2026, but hawkish comments from Fed Chair Kevin Warsh at the Jackson Hole symposium have pushed September rate hike odds as high as 66%, a sharp jump from under 40% just a week earlier. How many rate hikes do you expect from the Fed in 2026? Vote and explain your reasoning in the comments.

How many rate hikes do you expect from the Fed in 2026?

Feed

News

Sentiment

Earnings

Fundamentals

Info

RPRX Royalty Pharma plc - Ordinary Shares - Class A

Fundamentals

Latest RPRX News